InBody for reliable
body composition analysis in
diabetology
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
InBody applications

Advancing diabetes management through
body composition analysis
Effective diabetes care requires more than conventional weight metrics.
In diabetology, body composition analysis provides crucial insights into the interplay between body fat percentage, muscle mass, and metabolic health: factors that strongly influence insulin resistance and blood glucose control. Unlike BMI, InBody technology precisely measures visceral fat, skeletal muscle mass, and segmental body distribution, helping physicians identify the underlying causes of type 2 diabetes and related complications.
By incorporating body composition testing into diabetes management, healthcare professionals can enhance risk stratification, personalize nutritional and pharmacological interventions, and closely monitor treatment effectiveness. InBody’s clinically validated devices are used worldwide in hospitals, diabetes clinics, and research institutions, enabling evidence-based decisions and better treatment outcomes for patients with diabetes and metabolic disorders.
Advancing diabetes management through
body composition analysis
Effective diabetes care requires more than conventional weight metrics.
In diabetology, body composition analysis provides crucial insights into the interplay between body fat percentage, muscle mass, and metabolic health: factors that strongly influence insulin resistance and blood glucose control. Unlike BMI, InBody technology precisely measures visceral fat, skeletal muscle mass, and segmental body distribution, helping physicians identify the underlying causes of type 2 diabetes and related complications.
By incorporating body composition testing into diabetes management, healthcare professionals can enhance risk stratification, personalize nutritional and pharmacological interventions, and closely monitor treatment effectiveness. InBody’s clinically validated devices are used worldwide in hospitals, diabetes clinics, and research institutions, enabling evidence-based decisions and better treatment outcomes for patients with diabetes and metabolic disorders.

The clinical value of InBody in diabetology
Visceral
obesity
Precise quantification of visceral fat supports cardiovascular and metabolic risk stratification.
Sarcopenia
monitoring
Assessment of muscle mass and quality enables early detection of sarcopenia in patients with diabetes.
Insulin
resistance
Body composition analysis improves the identification of individuals at increased risk of insulin resistance.
Complication
screening
Segmental analysis helps detect early changes in body composition associated with diabetic complications.
Therapy
evaluation
Objective measurements allow healthcare professionals to monitor the effects of pharmacological and lifestyle interventions.
Support for
kidney function
Analysis of fluid compartments contributes to the early detection of imbalances associated with nephropathies.
Rehabilitation
planning
Quantitative data supports the development of individualized exercise and nutrition strategies in diabetes management.
Scientific
validation
Clinical applicability is supported by numerous peer-reviewed studies in diabetology and metabolic medicine.
The InBody BWA2.0S
in diabetology
The InBody BWA2.0S is particularly well suited to diabetology because it provides precise insights into body composition and fluid distribution, parameters closely linked to metabolic health and diabetic complications. Quantification of visceral fat enables accurate risk stratification for cardiovascular disease, while analysis of fat-free mass supports the early detection and management of sarcopenia, a common comorbidity in type 2 diabetes. By identifying subtle changes in body composition, the BWA2.0S helps detect complications such as insulin resistance, nephropathy-related fluid imbalances, and impaired muscle quality at an early stage.
In addition to its diagnostic value, the BWA2.0S also improves therapy monitoring by objectively capturing the effects of pharmacological treatments, lifestyle interventions, and nutritional measures on body composition. Biomarkers such as phase angle provide prognostic indications of cellular integrity and overall metabolic health, complementing conventional laboratory values. Thanks to fast, non-invasive measurements and strong validation through peer-reviewed studies, the BWA2.0S is a clinically reliable tool for diabetologists, both for individual patient care and long-term follow-up.

Trusted by
Add hospitals, practices, and clinics that use InBody


Results in just
30 seconds
An InBody measurement takes only 30 seconds, making it ideal for fast-paced environments such as hospitals, clinics, and other medical practices. Although InBody measurement results are available very quickly, accuracy, precision, and reliability remain uncompromised.
Fast and efficient body composition measurements can save lives in critical situations. They help healthcare professionals better understand the current situation and act accordingly, without delay and based on reliable data.
Results in just
30 seconds
An InBody measurement takes only 30 seconds, making it ideal for fast-paced environments such as hospitals, clinics, and other medical practices. Although InBody measurement results are available very quickly, accuracy, precision, and reliability remain uncompromised.
Fast and efficient body composition measurements can save lives in critical situations. They help healthcare professionals better understand the current situation and act accordingly, without delay and based on reliable data.
Testimonials
Contact us
"*" indicates required fields